Entity Details
Primary name |
SAP3_HUMAN |
Entity type |
UniProt |
Source |
Source Link |
Details
Accession | P17900 |
EntryName | SAP3_HUMAN |
FullName | Ganglioside GM2 activator |
TaxID | 9606 |
Evidence | evidence at protein level |
Length | 193 |
SequenceStatus | complete |
DateCreated | 1990-11-01 |
DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
Subcellular Location |
Lysosome |
Domains
Show/Hide Table
Domain | Name | Category | Type |
IPR003172 | MD-2-related lipid-recognition domain | Domain | Domain |
IPR028996 | Ganglioside GM2 activator | Family | Family |
IPR036846 | GM2-AP, lipid-recognition domain superfamily | Family | Homologous superfamily |
Diseases
Show/Hide Table
Disease ID | Source | Name | Description |
272750 | OMIM | GM2-gangliosidosis AB (GM2GAB) | An autosomal recessive lysosomal storage disease marked by the accumulation of GM2 gangliosides in the neuronal cells. It is characterized by GM2 gangliosides accumulation in the presence of both normal hexosaminidase A and B. The disease is caused by variants affecting the gene represented in this entry. |
Drugs
Show/Hide Table
Drug | Name | Source | Type |
DB02261 | Platelet Activating Factor | Drugbank | small molecule |
DB03017 | Lauric acid | Drugbank | small molecule |
DB03633 | Lpc-Ether | Drugbank | small molecule |
DB04660 | Choline alfoscerate | Drugbank | small molecule |
DB08231 | Myristic acid | Drugbank | small molecule |
Interactions
4 interactions